22246-05-5

Basic information

• Product Name: 7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE
• Synonyms: 7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE;3,4-Dihydro-7-hydroxy-1(2H)-isoquinolinone;7-Hydroxy-3,4-dihyrdro-2-H-isoquinolin-1-one;3,4-dihydroisoquinoline-1,7-diol;1(2H)-Isoquinolinone, 3,4-dihydro-7-hydroxy-
• CAS NO: 22246-05-5
• Molecular Formula: C₉H₉NO₂
• Molecular Weight: 163.17
• Mol File: 22246-05-5.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Density: 1.282
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE(22246-05-5)
• EPA Substance Registry System: 7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE(22246-05-5)

Safety Data

• Hazardous Substances Data: 22246-05-5(Hazardous Substances Data)

Usage

Description

7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE is an organic compound with the molecular formula C9H9NO2. It is a derivative of isoquinolinone, featuring a hydroxyl group at the 7th position and a dihydro structure. 7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE has potential applications in various fields due to its unique chemical properties and structure.

Uses

Used in Pharmaceutical Industry:
7-HYDROXY-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE is used as a key intermediate compound in the synthesis of various amine compounds. One of its primary applications is in the preparation of amine compounds that act as SSAO/VAP-1 inhibitors. These inhibitors have potential therapeutic applications in treating various diseases, including cancer, by targeting specific enzymes involved in the progression of the disease.

InChI:InChI=1/C9H9NO2/c11-7-2-1-6-3-4-10-9(12)8(6)5-7/h1-2,5,11H,3-4H2,(H,10,12)

Upstream product

• 22246-04-4 7-methoxy-3,4-dihydro-2H-isoquinolin-1-one 
• 13623-25-1 6-methoxy-2,3-dihydro-1H-inden-1-one 
• 91247-71-1 2-4-methoxyphenylethylcarbamic acid methyl ester 
• 62372-08-1 4-hydroxyphenyl-2-ethylcarbamic acid methyl ester 
• 55-81-2 4-Methoxyphenethylamine 
• 38480-95-4 6-methoxy-1H-inden-1-one 
• 83-33-0 inden-1-one 
• 1196-38-9 3,4-dihydroisoquinolin-1(2H)-one 
• 22245-96-1 7-nitro-3,4-dihydro-2H-isoquinolin-1-one 
• 66491-03-0 7-amino-3,4-dihydroisoquinoline-1(2H)-one 

Downstream Products

• 190604-11-6 7-(benzyloxy)-3,4-dihydroisoquinolin-1(2H)-one 
• 190604-12-7 (7-Benzyloxy-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl)-acetic acid tert-butyl ester 
• 190604-14-9 [7-(4-Cyano-benzyloxy)-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl]-acetic acid tert-butyl ester 
• 1027994-02-0 {6-[2-(4-Carbamimidoyl-phenyl)-ethoxy]-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl}-acetic acid tert-butyl ester 
• 1026177-04-7 [1-Oxo-7-(4-thiocarbamoyl-benzyloxy)-3,4-dihydro-1H-isoquinolin-2-yl]-acetic acid tert-butyl ester 
• 1027514-28-8 [7-(4-Carbamimidoyl-benzyloxy)-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl]-acetic acid tert-butyl ester 
• 1026846-42-3 [7-(4-Methylsulfanylcarbonimidoyl-benzyloxy)-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl]-acetic acid tert-butyl ester 
• 190604-15-0 {7-[4-(tert-Butoxycarbonylamino-imino-methyl)-benzyloxy]-1-oxo-3,4-dihydro-1H-isoquinolin-2-yl}-acetic acid tert-butyl ester 
• 1354030-55-9 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroisoquinolin-1(2H)-one 
• 1354030-67-3 7-(3-(4-(2,3-dichlorophenyl)piperazin-1-yl)propoxy)-3,4-dihydroisoquinolin-1(2H)-one 
• 1354030-69-5 7-(4-(4-(2,3-dichlorophenyl)piperidin-1-yl)butoxy)-3,4-dihydroisoquinolin-1(2H)-one 
• 1354030-23-1 7-(3-(4-(2,3-dichlorophenyl)-1,4-diazepan-1-yl)propoxy)-3,4-dihydroisoquinolin-1(2H)-one 
• 1354030-25-3 UNC₉₉₇₅ 
• 1231892-74-2 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one 

Relevant articles and documents

1,2,4-Triazole-3-Thione Analogues with a 2-Ethylbenzoic Acid at Position 4 as VIM-type Metallo-β-Lactamase Inhibitors

Metallo-β-lactamases (MBLs) are increasingly involved as a major mechanism of resistance to carbapenems in relevant opportunistic Gram-negative pathogens. Unfortunately, clinically efficient MBL inhibitors still represent an unmet medical need. We previou

AMINE COMPOUND FOR INHIBITING SSAO / VAP-1 AND USE THEREOF

An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.

Synthesis and pharmacological evaluation of new 3,4-dihydroisoquinolin derivatives containing heterocycle as potential anticonvulsant agents

Two novel series of 3,4-dihydroisoquinolin with heterocycle derivatives (4a-t and 9a-e) were synthesized and evaluated for their anticonvulsant activity using maximal electroshock (MES) test and pentylenetetrazole (PTZ)-induced seizure test. All compounds were characterized by IR, 1H-NMR, 13C-NMR, and mass spectral data. Among them, 9-(exyloxy)-5,6-dihydro-[1,2,4]triazolo[3,4-a] isoquinolin-3(2H)-one (9a) showed significant anticonvulsant activity in MES tests with an ED50 value of 63.31 mg/kg and it showed wide margins of safety with protective index (PI > 7.9). It showed much higher anticonvulsant activity than that of valproate. It also demonstrated potent activity against PTZ-induced seizures. A docking study of compound 9a in the benzodiazepine (BZD)-binding site of γ-aminobutyric acidA (GABAA) receptor confirmed possible binding of compound 9a with the BZD receptors.